Gunilla Lundmark

SampleFacts technology is based upon research carried out by Professor Ulf Landegren and Dr Johan Björksten at Uppsala University. Our vision is to develop intuitive devices that can eliminate barriers often associated with blood sample collection as performed during research, pre-clinical and clinical studies and, ultimately, for applications in the healthcare market. The SampleFacts company was founded in 2023 and is headquartered in Uppsala, Sweden.

Linnéa Capital makes investments in companies accepted to UIC Accelerator - a business development program provided by Uppsala Innovation Centre. Each accepted company is offered an initial investment of SEK 600 000, with the possibility for follow-on investments directly from Linnéa Capitals owners. Linnéa Capital is managed by UIC and funded by the Swedish state-owned company Saminvest in collaboration with a selected group of angel investors. For more information, please visit our website.

Lipidor AB is a Stockholm-based formulation research company. Its lipid based technology, AKVANO® represents an innovative dosage form consisting of water-free, sprayable liquid formulations in which selected lipids and the active ingredient are dissolved in a volatile solvent. The novel formulation technology offers unique product opportunities across dermatology, wound and skin care markets. The Company develops topical medical products for the treatment of diseases such as psoriasis, acne vulgaris, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.

SampleFacts technology is based upon research carried out by Professor Ulf Landegren and Dr Johan Björksten at Uppsala University. Our vision is to develop intuitive devices that can eliminate barriers often associated with blood sample collection as performed during research, pre-clinical and clinical studies and, ultimately, for applications in the healthcare market. The SampleFacts company was founded in 2023 and is headquartered in Uppsala, Sweden.

Linnéa Capital makes investments in companies accepted to UIC Accelerator - a business development program provided by Uppsala Innovation Centre. Each accepted company is offered an initial investment of SEK 600 000, with the possibility for follow-on investments directly from Linnéa Capitals owners. Linnéa Capital is managed by UIC and funded by the Swedish state-owned company Saminvest in collaboration with a selected group of angel investors. For more information, please visit our website.

CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization under its own management or in collaboration with other partners. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden. The company is public and listed on the Swedish marketplace Nasdaq First North and the company’s Certified Advisor is FNCA Sweden AB, +46 (0)852 80 03 99 info@fnca.se . For further information, please visit www.combigene.com. CombiGene’s lead project CG01 has received funding from the European Union’s Horizon 2020 research and innovation programme

Lipidor AB is a Stockholm-based formulation research company. Its lipid based technology, AKVANO® represents an innovative dosage form consisting of water-free, sprayable liquid formulations in which selected lipids and the active ingredient are dissolved in a volatile solvent. The novel formulation technology offers unique product opportunities across dermatology, wound and skin care markets. The Company develops topical medical products for the treatment of diseases such as psoriasis, acne vulgaris, bacterial skin infections and atopic dermatitis by reformulation of proven pharmaceutical substances.

UIC is one of Sweden’s leading business incubators and accelerators. We provide knowledge, network, financing and tailor made business development support and programs for innovative startups and entrepreneurs who want to develop their business, scale up or go internationally. With the guidance from UIC, our partners and wide network of business coaches, companies are better equipped to grow, avoid pitfalls and also save time and money at an early stage. UIC does not take ownership in the companies and is industry independent. We are located in Uppsala county (Sweden) and are part of Vinnova's Incubation Support - Excellence programme.